Difference between revisions of "Part:BBa K4414029"
Line 4: Line 4:
 
<partinfo>BBa_K4414029 short</partinfo>
 
<partinfo>BBa_K4414029 short</partinfo>
  
−
This composite part consists of an N-Terminal EGFP ([[BBa_K1123017]]) and a C-Terminal NR3C1 LBD ([[BBa_K4414000]]) domain. It is designed to sense glucocorticoids and locate glucocorticoid receptor (GR) in cells.
+
This composite part consists of an N-Terminal EGFP ([[Part:BBa_K1123017]]) and a C-Terminal NR3C1 LBD ([[Part:BBa_K4414000]]) domain. It is designed to sense glucocorticoids and locate glucocorticoid receptor (GR) in cells.
  
  
Line 20: Line 20:
  
 
</html>
 
</html>
−
Figure 1.Schematic figure of ([[BBa_K4414029]])
+
Figure 1.Schematic figure of BBa_K4414029.
 
===Sequecing===
 
===Sequecing===
 
The plasmid was sequenced correct.
 
The plasmid was sequenced correct.
Line 38: Line 38:
 
===Method===
 
===Method===
  
−
To test the ability of this part to respond to glucocorticoids, HEK-293T cells were co-transfected with plasmids encoding ([[BBa_K4414029]]). Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. The fluorescence intensity of cells was observed 24 h after posting glucocorticoids treatment.
+
To test the ability of this part to respond to glucocorticoids, HEK-293T cells were co-transfected with plasmids encoding BBa_K4414029. Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. The fluorescence intensity of cells was observed 24 h after posting glucocorticoids treatment.
 
===Result===
 
===Result===
  

Revision as of 07:01, 10 October 2022


EGFP-GGGSG-LBD

This composite part consists of an N-Terminal EGFP (Part:BBa_K1123017) and a C-Terminal NR3C1 LBD (Part:BBa_K4414000) domain. It is designed to sense glucocorticoids and locate glucocorticoid receptor (GR) in cells.


Usage and Biology

We constructed a plasmid to link LBD with the fluorescent protein EGFP to verify the function of LBD. The EGFP on the N-Terminal locates glucocorticoid reporter (GR). The NR3C1 LBD domain on the C-Terminal is a ligand binding domain of the glucocorticoid receptor (GR). This LBD domain can translocate the fusion protein into the nucleus upon glucocorticoid stimulation. It also has a trans-activating domain 2 (τ2) and an activation function domain 2 (AF2) which activates downstream gene expression[1].

Figure 1.Schematic figure of BBa_K4414029.

Sequecing

The plasmid was sequenced correct.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Fuctional test

Method

To test the ability of this part to respond to glucocorticoids, HEK-293T cells were co-transfected with plasmids encoding BBa_K4414029. Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. The fluorescence intensity of cells was observed 24 h after posting glucocorticoids treatment.

Result

Fluorescence images are shown below, which indicates that glucocorticoids can bind to LBD and enter the nucleus. This provides a basic direction of thinking for our experiments.

Figure 2.The picture on the left is Bright-field cell diagram, the picture in the middle is fluorescence diagram, and the picture on the right is merge diagram.

Reference

[1].Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol. 2017 Mar;18(3):159-174. doi: 10.1038/nrm.2016.152. Epub 2017 Jan 5. PMID: 28053348; PMCID: PMC6257982.